{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:05:04Z","timestamp":1792713904709,"version":"4.5.0"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T00:00:00Z","timestamp":1361232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T00:00:00Z","timestamp":1361232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1038\/nrgastro.2013.12","type":"journal-article","created":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T04:02:40Z","timestamp":1361246560000},"page":"245-255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":135,"title":["Progress and pitfalls in Shigella vaccine research"],"prefix":"10.1038","volume":"10","author":[{"given":"Eileen M.","family":"Barry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela F.","family":"Pasetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo B.","family":"Sztein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Kotloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron M.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,19]]},"reference":[{"key":"BFnrgastro201312_CR1","first-page":"651","volume":"77","author":"KL Kotloff","year":"1999","unstructured":"Kotloff, K. L.  et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. World Health Organ 77, 651\u2013666 (1999).","journal-title":"Bull. World Health Organ"},{"key":"BFnrgastro201312_CR2","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1093\/jac\/dkr341","volume":"66","author":"W Zhang","year":"2011","unstructured":"Zhang, W.  et al. Wide dissemination of multidrug-resistant Shigella isolates in China. J. Antimicrob. Chemother. 66, 2527\u20132535 (2011).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFnrgastro201312_CR3","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1099\/jmm.0.032920-0","volume":"60","author":"S Ghosh","year":"2011","unstructured":"Ghosh, S.  et al. Genetic characteristics and changing antimicrobial resistance among Shigella spp. isolated from hospitalized diarrhoeal patients in Kolkata, India. J. Med. Microbiol. 60, 1460\u20131466 (2011).","journal-title":"J. Med. Microbiol."},{"key":"BFnrgastro201312_CR4","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/1471-2334-9-204","volume":"9","author":"H Vinh","year":"2009","unstructured":"Vinh, H.  et al. A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation. BMC Infect. Dis. 9, 204 (2009).","journal-title":"BMC Infect. Dis."},{"key":"BFnrgastro201312_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1017\/S0950268810001093","volume":"139","author":"F Khatun","year":"2011","unstructured":"Khatun, F.  et al. Changing species distribution and antimicrobial susceptibility pattern of Shigella over a 29-year period (1980\u20132008). Epidemiol. Infect. 139, 446\u2013452 (2011).","journal-title":"Epidemiol. Infect."},{"key":"BFnrgastro201312_CR6","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1093\/jac\/dks061","volume":"67","author":"N Taneja","year":"2012","unstructured":"Taneja, N., Mewara, A., Kumar, A., Verma, G. & Sharma, M. Cephalosporin-resistant Shigella flexneri over 9 years (2001\u20132009) in India. J. Antimicrob. Chemother. 67, 1347\u20131353 (2012).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFnrgastro201312_CR7","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.carres.2011.02.013","volume":"346","author":"RA Foster","year":"2011","unstructured":"Foster, R. A.  et al. Structural elucidation of the O-antigen of the Shigella flexneri provisional serotype 88\u2013893: structural and serological similarities with S. flexneri provisional serotype Y394 (1c). Carbohydr. Res. 346, 872\u2013876 (2011).","journal-title":"Carbohydr. Res."},{"key":"BFnrgastro201312_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/infdis\/127.3.261","volume":"127","author":"MM Levine","year":"1973","unstructured":"Levine, M. M.  et al. Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery. J. Infect. Dis. 127, 261\u2013270 (1973).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro201312_CR9","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1056\/NEJM199111143252006","volume":"325","author":"KC Hyams","year":"1991","unstructured":"Hyams, K. C.  et al. Diarrheal disease during Operation Desert Shield. N. Engl. J. Med. 325, 1423\u20131428 (1991).","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 4","key":"BFnrgastro201312_CR10","doi-asserted-by":"publisher","first-page":"S232","DOI":"10.1093\/cid\/cis753","volume":"55","author":"K Kotloff","year":"2012","unstructured":"Kotloff, K.  et al. The Global Enterics Multicenter Study (GEMS) of diarrheal disease in young children in developing countries: epidemiologic and clinical methods of the case\/control study. Clin. Infect. Dis. 55 (Suppl. 4), S232\u2013S245 (2012).","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl. 4","key":"BFnrgastro201312_CR11","doi-asserted-by":"publisher","first-page":"S294","DOI":"10.1093\/cid\/cis754","volume":"55","author":"S Panchalingam","year":"2012","unstructured":"Panchalingam, S.  et al. Diagnostic microbiologic methods in the GEMS-1 Case\/Control Study. Clin. Infect. Dis. 55 (Suppl. 4), S294\u2013S302 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrgastro201312_CR12","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrmicro1662","volume":"5","author":"MM Levine","year":"2007","unstructured":"Levine, M. M., Kotloff, K. L., Barry, E. M., Pasetti, M. F. & Sztein, M. B. Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nat. Rev. Microbiol. 5, 540\u2013553 (2007).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFnrgastro201312_CR13","unstructured":"Centers for Disease Control and Prevention. Health status of displaced persons following Cival War\u2014Burundi, Dcemeber 1993\u2013January 1994. MMWR Morb. Mortal. Wkly Rep. 43, 701\u2013703 (1994)."},{"key":"BFnrgastro201312_CR14","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1128\/IAI.67.2.782-788.1999","volume":"67","author":"FR Noriega","year":"1999","unstructured":"Noriega, F. R.  et al. Strategy for cross-protection among Shigella flexneri serotypes. Infect. Immun. 67, 782\u2013788 (1999).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR15","doi-asserted-by":"publisher","first-page":"4432","DOI":"10.1093\/nar\/gkf566","volume":"30","author":"Q Jin","year":"2002","unstructured":"Jin, Q.  et al. Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 30, 4432\u20134441 (2002).","journal-title":"Nucleic Acids Res."},{"key":"BFnrgastro201312_CR16","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.1093\/nar\/gki954","volume":"33","author":"F Yang","year":"2005","unstructured":"Yang, F.  et al. Genome dynamics and diversity of Shigella species, the etiologic agents of bacillary dysentery. Nucleic Acids Res. 33, 6445\u20136458 (2005).","journal-title":"Nucleic Acids Res."},{"key":"BFnrgastro201312_CR17","doi-asserted-by":"publisher","first-page":"D398","DOI":"10.1093\/nar\/gkj033","volume":"34","author":"J Yang","year":"2006","unstructured":"Yang, J., Chen, L., Yu, J., Sun, L. & Jin, Q. ShiBASE: an integrated database for comparative genomics of Shigella. Nucleic Acids Res. 34, D398\u2013D401 (2006).","journal-title":"Nucleic Acids Res."},{"key":"BFnrgastro201312_CR18","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1128\/IAI.71.5.2775-2786.2003","volume":"71","author":"J Wei","year":"2003","unstructured":"Wei, J.  et al. Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect. Immun. 71, 2775\u20132786 (2003).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR19","doi-asserted-by":"publisher","first-page":"6880","DOI":"10.3748\/wjg.v11.i43.6880","volume":"11","author":"TY Ying","year":"2005","unstructured":"Ying, T. Y.  et al. Immunoproteomics of membrane proteins of Shigella flexneri 2a 2457T. World J. Gastroenterol. 11, 6880\u20136883 (2005).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro201312_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/sj.icb7100025","volume":"85","author":"A Phalipon","year":"2007","unstructured":"Phalipon, A. & Sansonetti, P. J. Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival? Immunol. Cell Biol. 85, 119\u2013129 (2007).","journal-title":"Immunol. Cell Biol."},{"key":"BFnrgastro201312_CR21","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1128\/CMR.00032-07","volume":"21","author":"GN Schroeder","year":"2008","unstructured":"Schroeder, G. N. & Hilbi, H. Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin. Microbiol. Rev. 21, 134\u2013156 (2008).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFnrgastro201312_CR22","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/infdis\/119.3.296","volume":"119","author":"HL DuPont","year":"1969","unstructured":"DuPont, H. L., Hornick, R. B., Dawkins, A. T., Snyder, M. J. & Formal, S. B. The response of man to virulent Shigella flexneri 2a. J. Infect. Dis. 119, 296\u2013299 (1969).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro201312_CR23","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/infdis\/153.6.1132","volume":"153","author":"DN Taylor","year":"1986","unstructured":"Taylor, D. N.  et al. The role of Shigella spp., enteroinvasive Escherichia coli, and other enteropathogens as causes of childhood dysentery in Thailand. J. Infect. Dis. 153, 1132\u20131138 (1986).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro201312_CR24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0016-5085(75)80008-4","volume":"68","author":"WR Rout","year":"1975","unstructured":"Rout, W. R., Formal, S. B., Giannella, R. A. & Dammin, G. J. Pathophysiology of Shigella diarrhea in the rhesus monkey: intestinal transport, morphological, and bacteriological studies. Gastroenterology 68, 270\u2013278 (1975).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201312_CR25","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1001\/archpedi.1987.04460020098036","volume":"141","author":"S Ashkenazi","year":"1987","unstructured":"Ashkenazi, S., Dinari, G., Zevulunov, A. & Nitzan, M. Convulsions in childhood shigellosis. Clinical and laboratory features in 153 children. Am. J. Dis. Child 141, 208\u2013210 (1987).","journal-title":"Am. J. Dis. Child"},{"key":"BFnrgastro201312_CR26","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1056\/NEJM197804272981702","volume":"298","author":"F Koster","year":"1978","unstructured":"Koster, F.  et al. Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. N. Engl. J. Med. 298, 927\u2013933 (1978).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201312_CR27","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/infdis\/152.4.784","volume":"152","author":"MJ Struelens","year":"1985","unstructured":"Struelens, M. J.  et al. Shigella septicemia: prevalence, presentation, risk factors, and outcome. J. Infect. Dis. 152, 784\u2013790 (1985).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro201312_CR28","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1097\/00002030-199212000-00012","volume":"6","author":"MR Nelson","year":"1992","unstructured":"Nelson, M. R., Shanson, D. C., Hawkins, D. A. & Gazzard, B. G. Salmonella, Campylobacter and Shigella in HIV-seropositive patients. AIDS 6, 1495\u20131498 (1992).","journal-title":"AIDS"},{"key":"BFnrgastro201312_CR29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/gut.40.4.505","volume":"40","author":"A Fasano","year":"1997","unstructured":"Fasano, A., Noriega, F. R., Liao, F. M., Wang, W. & Levine, M. M. Effect of Shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo. Gut 40, 505\u2013511 (1997).","journal-title":"Gut"},{"key":"BFnrgastro201312_CR30","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1172\/JCI117991","volume":"95","author":"A Fasano","year":"1995","unstructured":"Fasano, A.  et al. Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro. J. Clin. Invest. 95, 2853\u20132861 (1995).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201312_CR31","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1574-695X.2011.00778.x","volume":"61","author":"MJ Farfan","year":"2011","unstructured":"Farfan, M. J., Toro, C. S., Barry, E. M. & Nataro, J. P. Shigella enterotoxin-2 is a type III effector that participates in Shigella-induced interleukin 8 secretion by epithelial cells. FEMS Immunol. Med. Microbiol. 61, 332\u2013339 (2011).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"BFnrgastro201312_CR32","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1086\/424680","volume":"190","author":"KL Kotloff","year":"2004","unstructured":"Kotloff, K. L.  et al. Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208. J. Infect. Dis. 190, 1745\u20131754 (2004).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro201312_CR33","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4161\/hv.4746","volume":"3","author":"KL Kotloff","year":"2007","unstructured":"Kotloff, K. L.  et al. Safety and Immunogenicity of CVD 1208S, a live, oral \u0394guaBA \u0394sen \u0394set Shigella flexneri 2a vaccine grown on animal-free media. Hum. Vaccin. 3, 268\u2013275 (2007).","journal-title":"Hum. Vaccin."},{"key":"BFnrgastro201312_CR34","doi-asserted-by":"publisher","first-page":"5159","DOI":"10.1016\/j.vaccine.2012.05.003","volume":"30","author":"RT Ranallo","year":"2012","unstructured":"Ranallo, R. T.  et al. Two live attenuated Shigella flexneri 2a strains WRSf2G12 and WRSf2G15: A new combination of gene deletions for 2nd generation live attenuated vaccine candidates. Vaccine 30, 5159\u20135171 (2012).","journal-title":"Vaccine"},{"key":"BFnrgastro201312_CR35","doi-asserted-by":"publisher","first-page":"244","DOI":"10.4161\/gmic.2.4.17042","volume":"2","author":"L Bedford","year":"2011","unstructured":"Bedford, L.  et al. Further characterization of Shigella sonnei live vaccine candidates WRSs2 and WRSs3-plasmid composition, invasion assays and Sereny reactions. Gut Microbes 2, 244\u2013251 (2011).","journal-title":"Gut Microbes"},{"key":"BFnrgastro201312_CR36","doi-asserted-by":"publisher","first-page":"7105","DOI":"10.1128\/IAI.70.12.7105-7113.2002","volume":"70","author":"PR Dutta","year":"2002","unstructured":"Dutta, P. R., Cappello, R., Navarro-Garcia, F. & Nataro, J. P. Functional comparison of serine protease autotransporters of Enterobacteriaceae. Infect. Immun. 70, 7105\u20137113 (2002).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR37","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1128\/IAI.68.5.2457-2463.2000","volume":"68","author":"K Al-Hasani","year":"2000","unstructured":"Al-Hasani, K.  et al. The sigA gene which is borne on the she pathogenicity island of Shigella flexneri 2a encodes an exported cytopathic protease involved in intestinal fluid accumulation. Infect. Immun. 68, 2457\u20132463 (2000).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR38","unstructured":"Czerkinsky, C. & Kim, D. W. Novel Shigella protein antigens and methods. US Patent 8168203 [US2010\/0136045] (2010)."},{"key":"BFnrgastro201312_CR39","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1099\/00221287-144-7-1815","volume":"144","author":"Z Benjelloun-Touimi","year":"1998","unstructured":"Benjelloun-Touimi, Z., Si, T. M., Montecucco, C., Sansonetti, P. J. & Parsot, C. SepA, the 110 kDa protein secreted by Shigella flexneri: two-domain structure and proteolytic activity. Microbiology 144, 1815\u20131822 (1998).","journal-title":"Microbiology"},{"key":"BFnrgastro201312_CR40","doi-asserted-by":"publisher","first-page":"e49980","DOI":"10.1371\/journal.pone.0049980","volume":"7","author":"C Faherty","year":"2012","unstructured":"Faherty, C.  et al. Chromosomal and plasmid-encoded factors of Shigella flexneri induce secretogenic activity ex vivo. PLoS ONE 7, e49980 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrgastro201312_CR41","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1128\/IAI.67.11.5587-5596.1999","volume":"67","author":"IR Henderson","year":"1999","unstructured":"Henderson, I. R., Czeczulin, J., Eslava, C., Noriega, F. & Nataro, J. P. Characterization of Pic, a secreted protease of Shigella flexneri and enteroaggregative Escherichia coli. Infect. Immun. 67, 5587\u20135596 (1999).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR42","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1128\/IAI.70.6.2915-2925.2002","volume":"70","author":"M Behrens","year":"2002","unstructured":"Behrens, M., Sheikh, J. & Nataro, J. P. Regulation of the overlapping pic\/set locus in Shigella flexneri and enteroaggregative Escherichia coli. Infect. Immun. 70, 2915\u20132925 (2002).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR43","doi-asserted-by":"publisher","first-page":"12881","DOI":"10.1073\/pnas.1101006108","volume":"108","author":"F Ruiz-Perez","year":"2011","unstructured":"Ruiz-Perez, F.  et al. Serine protease autotransporters from Shigella flexneri and pathogenic Escherichia coli target a broad range of leukocyte glycoproteins. Proc. Natl Acad. Sci. USA 108, 12881\u201312886 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201312_CR44","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4269\/ajtmh.2009.80.294","volume":"80","author":"N Boisen","year":"2009","unstructured":"Boisen, N., Ruiz-Perez, F., Scheutz, F., Krogfelt, K. A. & Nataro, J. P. Short report: high prevalence of serine protease autotransporter cytotoxins among strains of enteroaggregative Escherichia coli. Am. J. Trop. Med. Hyg. 80, 294\u2013301 (2009).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFnrgastro201312_CR45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1128\/jb.92.1.17-22.1966","volume":"92","author":"SB Formal","year":"1966","unstructured":"Formal, S. B.  et al. Protection of monkeys against experimental shigellosis with a living attenuated oral polyvalent dysentery vaccine. J. Bacteriol. 92, 17\u201322 (1966).","journal-title":"J. Bacteriol."},{"key":"BFnrgastro201312_CR46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/jb.90.1.63-68.1965","volume":"90","author":"SB Formal","year":"1965","unstructured":"Formal, S. B., LaBrec, E. H., Palmer, A. & Falkow, S. Protection of monkeys against experimental shigellosis with attenuated vaccines. J. Bacteriol. 90, 63\u201368 (1965).","journal-title":"J. Bacteriol."},{"key":"BFnrgastro201312_CR47","first-page":"54","volume":"60","author":"ST Shipley","year":"2010","unstructured":"Shipley, S. T.  et al. A challenge model for Shigella dysenteriae 1 in cynomolgus monkeys (Macaca fascicularis). Comp. Med. 60, 54\u201361 (2010).","journal-title":"Comp. Med."},{"key":"BFnrgastro201312_CR48","first-page":"61","volume":"46","author":"ME Etheridge","year":"1996","unstructured":"Etheridge, M. E., Hoque, A. T. & Sack, D. A. Pathologic study of a rabbit model for shigellosis. Lab. Anim. Sci. 46, 61\u201366 (1996).","journal-title":"Lab. Anim. Sci."},{"key":"BFnrgastro201312_CR49","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1128\/iai.63.11.4350-4357.1995","volume":"63","author":"GH Rabbani","year":"1995","unstructured":"Rabbani, G. H.  et al. Development of an improved animal model of shigellosis in the adult rabbit by colonic infection with Shigella flexneri 2a. Infect. Immun. 63, 4350\u20134357 (1995).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR50","first-page":"293","volume":"2","author":"B Sereny","year":"1955","unstructured":"Sereny, B. Experimental Shigella keratoconjunctivitis; a preliminary report. Acta Microbiol. Acad. Sci. Hung. 2, 293\u2013296 (1955).","journal-title":"Acta Microbiol. Acad. Sci. Hung."},{"key":"BFnrgastro201312_CR51","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/0264-410X(93)90016-Q","volume":"11","author":"CP Mallett","year":"1993","unstructured":"Mallett, C. P., VanDeVerg, L., Collins, H. H. & Hale, T. L. Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model. Vaccine 11, 190\u2013196 (1993).","journal-title":"Vaccine"},{"key":"BFnrgastro201312_CR52","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.4049\/jimmunol.178.4.2476","volume":"178","author":"DH Shim","year":"2007","unstructured":"Shim, D. H.  et al. New animal model of shigellosis in the Guinea pig: its usefulness for protective efficacy studies. J. Immunol. 178, 2476\u20132482 (2007).","journal-title":"J. Immunol."},{"key":"BFnrgastro201312_CR53","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1128\/iai.63.12.4721-4728.1995","volume":"63","author":"JP Nataro","year":"1995","unstructured":"Nataro, J. P.  et al. Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains. Infect. Immun. 63, 4721\u20134728 (1995).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR54","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/infdis\/164.3.533","volume":"164","author":"SB Formal","year":"1991","unstructured":"Formal, S. B.  et al. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei. J. Infect. Dis. 164, 533\u2013537 (1991).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro201312_CR55","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/0264-410X(90)90094-3","volume":"8","author":"DA Herrington","year":"1990","unstructured":"Herrington, D. A.  et al. Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi\u2013Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease. Vaccine 8, 353\u2013357 (1990).","journal-title":"Vaccine"},{"key":"BFnrgastro201312_CR56","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/0264-410X(95)00102-7","volume":"13","author":"KL Kotloff","year":"1995","unstructured":"Kotloff, K. L.  et al. A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity. Vaccine 13, 1488\u20131494 (1995).","journal-title":"Vaccine"},{"key":"BFnrgastro201312_CR57","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/oxfordjournals.aje.a116134","volume":"134","author":"C Ferreccio","year":"1991","unstructured":"Ferreccio, C.  et al. Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile. Am. J. Epidemiol. 134, 614\u2013627 (1991).","journal-title":"Am. J. Epidemiol."},{"key":"BFnrgastro201312_CR58","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/01.inf.0000078156.03697.a5","volume":"22","author":"JH Passwell","year":"2003","unstructured":"Passwell, J. H.  et al. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children. Pediatr. Infect. Dis. J. 22, 701\u2013706 (2003).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"BFnrgastro201312_CR59","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/clinids\/15.2.346","volume":"15","author":"JB Robbins","year":"1992","unstructured":"Robbins, J. B., Chu, C. & Schneerson, R. Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides. Clin. Infect. Dis. 15, 346\u2013361 (1992).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrgastro201312_CR60","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1128\/iai.61.9.3678-3687.1993","volume":"61","author":"DN Taylor","year":"1993","unstructured":"Taylor, D. N.  et al. Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids. Infect. Immun. 61, 3678\u20133687 (1993).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR61","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1128\/iai.64.10.4074-4077.1996","volume":"64","author":"D Cohen","year":"1996","unstructured":"Cohen, D.  et al. Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers. Infect. Immun. 64, 4074\u20134077 (1996).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR62","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.vaccine.2009.12.050","volume":"28","author":"JH Passwell","year":"2010","unstructured":"Passwell, J. H.  et al. Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children. Vaccine 28, 2231\u20132235 (2010).","journal-title":"Vaccine"},{"key":"BFnrgastro201312_CR63","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1475-2859-9-61","volume":"9","author":"J Ihssen","year":"2010","unstructured":"Ihssen, J.  et al. Production of glycoprotein vaccines in Escherichia coli. Microb. Cell Fact. 9, 61 (2010).","journal-title":"Microb. Cell Fact."},{"key":"BFnrgastro201312_CR64","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1073\/pnas.0500044102","volume":"102","author":"MF Feldman","year":"2005","unstructured":"Feldman, M. F.  et al. Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli. Proc. Natl Acad. Sci. USA 102, 3016\u20133021 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201312_CR65","unstructured":"Dro, P. & Sinclair, M. GlycoVaxyn Phase I clinical study shows positive data with Shigella dysenteriae vaccine candidate [online], (2010)."},{"key":"BFnrgastro201312_CR66","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.4049\/jimmunol.0803141","volume":"182","author":"A Phalipon","year":"2009","unstructured":"Phalipon, A.  et al. A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection. J. Immunol. 182, 2241\u20132247 (2009).","journal-title":"J. Immunol."},{"key":"BFnrgastro201312_CR67","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.4049\/jimmunol.176.3.1686","volume":"176","author":"A Phalipon","year":"2006","unstructured":"Phalipon, A.  et al. Characterization of functional oligosaccharide mimics of the Shigella flexneri serotype 2a O-antigen: implications for the development of a chemically defined glycoconjugate vaccine. J. Immunol. 176, 1686\u20131694 (2006).","journal-title":"J. Immunol."},{"key":"BFnrgastro201312_CR68","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.vaccine.2006.11.012","volume":"25","author":"M Osorio","year":"2007","unstructured":"Osorio, M., Bray, M. D. & Walker, R. I. Vaccine potential for inactivated shigellae. Vaccine 25, 1581\u20131592 (2007).","journal-title":"Vaccine"},{"key":"BFnrgastro201312_CR69","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1016\/j.vaccine.2005.07.014","volume":"24","author":"R McKenzie","year":"2006","unstructured":"McKenzie, R.  et al. Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial. Vaccine 24, 3735\u20133745 (2006).","journal-title":"Vaccine"},{"key":"BFnrgastro201312_CR70","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1017\/S0950268812001677","volume":"141","author":"CK Porter","year":"2013","unstructured":"Porter, C. K., Thura, N., Ranallo, R. T. & Riddle, M. S. The Shigella human challenge model. Epidemiol. Infect. 141, 223\u2013232 (2013).","journal-title":"Epidemiol. Infect."},{"key":"BFnrgastro201312_CR71","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/IAI.67.7.3437-3443.1999","volume":"67","author":"TS Coster","year":"1999","unstructured":"Coster, T. S.  et al. Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602. Infect. Immun. 67, 3437\u20133443 (1999).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR72","first-page":"647","volume":"32","author":"DM Mel","year":"1965","unstructured":"Mel, D. M., Terzin, A. L. & Vuksic, L. Studies on vaccination against bacillary dysentery. 3. Effective oral immunization against Shigella flexneri 2a in a field trial. Bull. World Health Organ. 32, 647\u2013655 (1965).","journal-title":"Bull. World Health Organ."},{"key":"BFnrgastro201312_CR73","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1574-695X.2006.00118.x","volume":"47","author":"RT Ranallo","year":"2006","unstructured":"Ranallo, R. T., Barnoy, S., Thakkar, S., Urick, T. & Venkatesan, M. M. Developing live Shigella vaccines using lambda Red recombineering. FEMS Immunol. Med. Microbiol. 47, 462\u2013469 (2006).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"BFnrgastro201312_CR74","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1586\/14760584.5.5.669","volume":"5","author":"MM Venkatesan","year":"2006","unstructured":"Venkatesan, M. M. & Ranallo, R. T. Live-attenuated Shigella vaccines. Expert Rev. Vaccines 5, 669\u2013686 (2006).","journal-title":"Expert Rev. Vaccines"},{"key":"BFnrgastro201312_CR75","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1016\/j.vaccine.2011.04.115","volume":"29","author":"S Barnoy","year":"2011","unstructured":"Barnoy, S.  et al. Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infection. Vaccine 29, 6371\u20136378 (2011).","journal-title":"Vaccine"},{"key":"BFnrgastro201312_CR76","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1128\/IAI.00533-09","volume":"78","author":"RT Ranallo","year":"2010","unstructured":"Ranallo, R. T.  et al. Virulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutants. Infect. Immun. 78, 400\u2013412 (2010).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR77","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1128\/IAI.72.2.923-930.2004","volume":"72","author":"DE Katz","year":"2004","unstructured":"Katz, D. E.  et al. Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers. Infect. Immun. 72, 923\u2013930 (2004).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR78","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.vaccine.2010.10.035","volume":"29","author":"KM Rahman","year":"2011","unstructured":"Rahman, K. M.  et al. Safety, dose, immunogenicity, and transmissibility of an oral live attenuated Shigella flexneri 2a vaccine candidate (SC602) among healthy adults and school children in Matlab, Bangladesh. Vaccine 29, 1347\u20131354 (2011).","journal-title":"Vaccine"},{"key":"BFnrgastro201312_CR79","doi-asserted-by":"publisher","first-page":"137ps12","DOI":"10.1126\/scitranslmed.3004347","volume":"4","author":"JI Gordon","year":"2012","unstructured":"Gordon, J. I., Dewey, K. G., Mills, D. A. & Medzhitov, R. M. The human gut microbiota and undernutrition. Sci. Transl. Med. 4, 137ps12 (2012).","journal-title":"Sci. Transl. Med."},{"key":"BFnrgastro201312_CR80","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1741-7007-8-129","volume":"8","author":"MM Levine","year":"2010","unstructured":"Levine, M. M. Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine. BMC Biol. 8, 129 (2010).","journal-title":"BMC Biol."},{"key":"BFnrgastro201312_CR81","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/S0140-6736(87)90649-0","volume":"1","author":"P Hanlon","year":"1987","unstructured":"Hanlon, P.  et al. Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet 1, 1342\u20131345 (1987).","journal-title":"Lancet"},{"key":"BFnrgastro201312_CR82","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/oxfordjournals.aje.a121457","volume":"96","author":"TJ John","year":"1972","unstructured":"John, T. J. & Jayabal, P. Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference. Am. J. Epidemiol. 96, 263\u2013269 (1972).","journal-title":"Am. J. Epidemiol."},{"key":"BFnrgastro201312_CR83","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","volume":"376","author":"GE Armah","year":"2010","unstructured":"Armah, G. E.  et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 376, 606\u2013614 (2010).","journal-title":"Lancet"},{"key":"BFnrgastro201312_CR84","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/ije\/19.3.711","volume":"19","author":"V Balraj","year":"1990","unstructured":"Balraj, V., John, T. J., Thomas, M. & Mukundan, S. Efficacy of oral poliovirus vaccine in rural communities of North Arcot District, India. Int. J. Epidemiol. 19, 711\u2013714 (1990).","journal-title":"Int. J. Epidemiol."},{"key":"BFnrgastro201312_CR85","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1056\/NEJMoa0904797","volume":"362","author":"SA Madhi","year":"2010","unstructured":"Madhi, S. A.  et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N. Engl. J. Med. 362, 289\u2013298 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201312_CR86","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/infdis\/165.6.1042","volume":"165","author":"P Su-Arehawaratana","year":"1992","unstructured":"Su-Arehawaratana, P.  et al. Safety and immunogenicity of different immunization regimens of CVD 103-HgR live oral cholera vaccine in soldiers and civilians in Thailand. J. Infect. Dis. 165, 1042\u20131048 (1992).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro201312_CR87","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.vaccine.2007.12.040","volume":"26","author":"KR Turbyfill","year":"2008","unstructured":"Turbyfill, K. R., Kaminski, R. W. & Oaks, E. V. Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2a. Vaccine 26, 1353\u20131364 (2008).","journal-title":"Vaccine"},{"key":"BFnrgastro201312_CR88","doi-asserted-by":"publisher","first-page":"7009","DOI":"10.1016\/j.vaccine.2011.07.033","volume":"29","author":"MS Riddle","year":"2011","unstructured":"Riddle, M. S.  et al. Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine. Vaccine 29, 7009\u20137019 (2011).","journal-title":"Vaccine"},{"key":"BFnrgastro201312_CR89","doi-asserted-by":"publisher","first-page":"6076","DOI":"10.1016\/j.vaccine.2010.06.086","volume":"28","author":"D Tribble","year":"2010","unstructured":"Tribble, D.  et al. Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers. Vaccine 28, 6076\u20136085 (2010).","journal-title":"Vaccine"},{"key":"BFnrgastro201312_CR90","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1128\/IAI.06174-11","volume":"80","author":"FJ Martinez-Becerra","year":"2012","unstructured":"Martinez-Becerra, F. J.  et al. Broadly protective Shigella vaccine based on type III secretion apparatus proteins. Infect. Immun. 80, 1222\u20131231 (2012).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR91","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3109\/00365549409008617","volume":"26","author":"A Li","year":"1994","unstructured":"Li, A., Zhao, C. R., Ekwall, E. & Lindberg, A. A. Serum IgG antibody responses to Shigella invasion plasmid-coded antigens detected by immunoblot. Scand. J. Infect. Dis. 26, 435\u2013445 (1994).","journal-title":"Scand. J. Infect. Dis."},{"key":"BFnrgastro201312_CR92","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/iai.53.1.57-63.1986","volume":"53","author":"EV Oaks","year":"1986","unstructured":"Oaks, E. V., Hale, T. L. & Formal, S. B. Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp. Infect. Immun. 53, 57\u201363 (1986).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR93","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/iai.30.2.321-324.1980","volume":"30","author":"G Adamus","year":"1980","unstructured":"Adamus, G., Mulczyk, M., Witkowska, D. & Romanowska, E. Protection against keratoconjunctivitis shigellosa induced by immunization with outer membrane proteins of Shigella spp. Infect. Immun. 30, 321\u2013324 (1980).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR94","doi-asserted-by":"publisher","first-page":"e22663","DOI":"10.1371\/journal.pone.0022663","volume":"6","author":"D Pore","year":"2011","unstructured":"Pore, D., Mahata, N., Pal, A. & Chakrabarti, M. K. Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model. PLoS ONE 6, e22663 (2011).","journal-title":"PLoS ONE"},{"key":"BFnrgastro201312_CR95","doi-asserted-by":"publisher","first-page":"e35616","DOI":"10.1371\/journal.pone.0035616","volume":"7","author":"F Berlanda Scorza","year":"2012","unstructured":"Berlanda Scorza, F.  et al. High yield production process for Shigella outer membrane particles. PLoS ONE 7, e35616 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrgastro201312_CR96","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1086\/516452","volume":"175","author":"G Robin","year":"1997","unstructured":"Robin, G.  et al. Characterization and quantitative analysis of serum IgG class and subclass response to Shigella sonnei and Shigella flexneri 2a lipopolysaccharide following natural Shigella infection. J. Infect. Dis. 175, 1128\u20131133 (1997).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro201312_CR97","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/infdis\/157.5.1068","volume":"157","author":"D Cohen","year":"1988","unstructured":"Cohen, D., Green, M. S., Block, C., Rouach, T. & Ofek, I. Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population. J. Infect. Dis. 157, 1068\u20131071 (1988).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro201312_CR98","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/jcm.29.2.386-389.1991","volume":"29","author":"D Cohen","year":"1991","unstructured":"Cohen, D., Green, M. S., Block, C., Slepon, R. & Ofek, I. Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis. J. Clin. Microbiol. 29, 386\u2013389 (1991).","journal-title":"J. Clin. Microbiol."},{"key":"BFnrgastro201312_CR99","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/infdis\/166.1.158","volume":"166","author":"LL Van De Verg","year":"1992","unstructured":"Van De Verg, L. L., Herrington, D. A., Boslego, J., Lindberg, A. A. & Levine, M. M. Age-specific prevalence of serum antibodies to the invasion plasmid and lipopolysaccharide antigens of Shigella species in Chilean and North American populations. J. Infect. Dis. 166, 158\u2013161 (1992).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro201312_CR100","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1128\/iai.59.7.2341-2350.1991","volume":"59","author":"RA Oberhelman","year":"1991","unstructured":"Oberhelman, R. A.  et al. Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides. Infect. Immun. 59, 2341\u20132350 (1991).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR101","first-page":"429","volume":"29","author":"MA Sayem","year":"2011","unstructured":"Sayem, M. A.  et al. Differential host immune responses to epidemic and endemic strains of Shigella dysenteriae type I. J. Health Popul. Nutr. 29, 429\u2013437 (2011).","journal-title":"J. Health Popul. Nutr."},{"key":"BFnrgastro201312_CR102","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.4049\/jimmunol.125.6.2778","volume":"125","author":"GH Lowell","year":"1980","unstructured":"Lowell, G. H.  et al. Antibody-dependent cell-mediated antibacterial activity: K lymphocytes, monocytes, and granulocytes are effective against Shigella. J. Immunol. 125, 2778\u20132784 (1980).","journal-title":"J. Immunol."},{"key":"BFnrgastro201312_CR103","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1128\/iai.64.11.4542-4548.1996","volume":"64","author":"KL Kotloff","year":"1996","unstructured":"Kotloff, K. L.  et al. Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG. Infect. Immun. 64, 4542\u20134548 (1996).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR104","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0264-410X(94)00011-B","volume":"13","author":"KL Kotloff","year":"1995","unstructured":"Kotloff, K. L.  et al. Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli\u2013Shigella flexneri 2a vaccine strain EcSf2a-2. Vaccine 13, 495\u2013502 (1995).","journal-title":"Vaccine"},{"key":"BFnrgastro201312_CR105","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S0022-3476(05)80327-0","volume":"121","author":"KC Hayani","year":"1992","unstructured":"Hayani, K. C.  et al. Concentration of milk secretory immunoglobulin A against Shigella virulence plasmid-associated antigens as a predictor of symptom status in Shigella-infected breast-fed infants. J. Pediatr. 121, 852\u2013856 (1992).","journal-title":"J. Pediatr."},{"key":"BFnrgastro201312_CR106","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1128\/iai.57.6.1675-1679.1989","volume":"57","author":"TG Cleary","year":"1989","unstructured":"Cleary, T. G., Winsor, D. K., Reich, D., Ruiz-Palacios, G. & Calva, J. J. Human milk immunoglobulin A antibodies to Shigella virulence determinants. Infect. Immun. 57, 1675\u20131679 (1989).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR107","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0140-6736(96)06255-1","volume":"349","author":"D Cohen","year":"1997","unstructured":"Cohen, D.  et al. Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults. Lancet 349, 155\u2013159 (1997).","journal-title":"Lancet"},{"key":"BFnrgastro201312_CR108","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1128\/iai.63.1.289-296.1995","volume":"63","author":"R Raqib","year":"1995","unstructured":"Raqib, R.  et al. Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect. Immun. 63, 289\u2013296 (1995).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR109","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1046\/j.1365-3083.2002.01079.x","volume":"55","author":"R Raqib","year":"2002","unstructured":"Raqib, R.  et al. Delayed and reduced adaptive humoral immune responses in children with shigellosis compared with in adults. Scand. J. Immunol. 55, 414\u2013423 (2002).","journal-title":"Scand. J. Immunol."},{"key":"BFnrgastro201312_CR110","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1034\/j.1600-0463.2000.d01-52.x","volume":"108","author":"D Islam","year":"2000","unstructured":"Islam, D. & Christensson, B. Disease-dependent changes in T-cell populations in patients with shigellosis. APMIS 108, 251\u2013260 (2000).","journal-title":"APMIS"},{"key":"BFnrgastro201312_CR111","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/iai.63.8.2941-2949.1995","volume":"63","author":"D Islam","year":"1995","unstructured":"Islam, D., Bardhan, P. K., Lindberg, A. A. & Christensson, B. Shigella infection induces cellular activation of T and B cells and distinct species-related changes in peripheral blood lymphocyte subsets during the course of the disease. Infect. Immun. 63, 2941\u20132949 (1995).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR112","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1128\/iai.64.4.1391-1399.1996","volume":"64","author":"D Islam","year":"1996","unstructured":"Islam, D., Wretlind, B., Lindberg, A. A. & Christensson, B. Changes in the peripheral blood T-cell receptor V beta repertoire in vivo and in vitro during shigellosis. Infect. Immun. 64, 1391\u20131399 (1996).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR113","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.smim.2008.07.007","volume":"21","author":"S Manicassamy","year":"2009","unstructured":"Manicassamy, S. & Pulendran, B. Retinoic acid-dependent regulation of immune responses by dendritic cells and macrophages. Semin. Immunol. 21, 22\u201327 (2009).","journal-title":"Semin. Immunol."},{"key":"BFnrgastro201312_CR114","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/nri3322","volume":"12","author":"O Pabst","year":"2012","unstructured":"Pabst, O. New concepts in the generation and functions of IgA. Nat. Rev. Immunol. 12, 821\u2013832 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrgastro201312_CR115","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.smim.2007.12.006","volume":"20","author":"I Sanz","year":"2008","unstructured":"Sanz, I., Wei, C., Lee, F. E. & Anolik, J. Phenotypic and functional heterogeneity of human memory B cells. Semin. Immunol. 20, 67\u201382 (2008).","journal-title":"Semin. Immunol."},{"key":"BFnrgastro201312_CR116","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.vaccine.2008.10.081","volume":"27","author":"JK Simon","year":"2009","unstructured":"Simon, J. K.  et al. Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidates. Vaccine 27, 565\u2013572 (2009).","journal-title":"Vaccine"},{"key":"BFnrgastro201312_CR117","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.clim.2011.02.003","volume":"139","author":"JK Simon","year":"2011","unstructured":"Simon, J. K.  et al. Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates. Clin. Immunol. 139, 185\u2013192 (2011).","journal-title":"Clin. Immunol."},{"issue":"Suppl. 2","key":"BFnrgastro201312_CR118","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/S0264-410X(03)00198-1","volume":"21","author":"E Traggiai","year":"2003","unstructured":"Traggiai, E., Puzone, R. & Lanzavecchia, A. Antigen dependent and independent mechanisms that sustain serum antibody levels. Vaccine 21 (Suppl. 2), S35\u2013S37 (2003).","journal-title":"Vaccine"},{"key":"BFnrgastro201312_CR119","doi-asserted-by":"publisher","first-page":"5432","DOI":"10.1016\/j.vaccine.2009.06.107","volume":"27","author":"JS Gaston","year":"2009","unstructured":"Gaston, J. S.  et al. Vaccination of children in low-resource countries against Shigella is unlikely to present an undue risk of reactive arthritis. Vaccine 27, 5432\u20135434 (2009).","journal-title":"Vaccine"},{"key":"BFnrgastro201312_CR120","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1093\/infdis\/172.5.1408","volume":"172","author":"FR Noriega","year":"1995","unstructured":"Noriega, F. R., Liao, F. M., Formal, S. B., Fasano, A. & Levine, M. M. Prevalence of Shigella enterotoxin 1 among Shigella clinical isolates of diverse serotypes. J. Infect. Dis. 172, 1408\u20131410 (1995).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro201312_CR121","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1365-2958.1995.mmi_17010123.x","volume":"17","author":"Z Benjelloun-Touimi","year":"1995","unstructured":"Benjelloun-Touimi, Z., Sansonetti, P. J. & Parsot, C. SepA, the major extracellular protein of Shigella flexneri: autonomous secretion and involvement in tissue invasion. Mol. Microbiol. 17, 123\u2013135 (1995).","journal-title":"Mol. Microbiol."},{"key":"BFnrgastro201312_CR122","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.1128\/IAI.05814-11","volume":"79","author":"T Wu","year":"2011","unstructured":"Wu, T., Grassel, C., Levine, M. M. & Barry, E. M. Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit. Infect. Immun. 79, 4912\u20134922 (2011).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR123","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1128\/IAI.70.4.2016-2021.2002","volume":"70","author":"KL Kotloff","year":"2002","unstructured":"Kotloff, K. L.  et al. Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults. Infect. Immun. 70, 2016\u20132021 (2002).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR124","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.vaccine.2009.11.001","volume":"28","author":"S Barnoy","year":"2010","unstructured":"Barnoy, S.  et al. Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity. Vaccine 28, 1642\u20131654 (2010).","journal-title":"Vaccine"},{"key":"BFnrgastro201312_CR125","first-page":"88","volume":"58","author":"TA Collins","year":"2008","unstructured":"Collins, T. A.  et al. Safety and colonization of two novel VirG(IcsA)-based live Shigella sonnei vaccine strains in rhesus macaques (Macaca mulatta). Comp. Med. 58, 88\u201394 (2008).","journal-title":"Comp. Med."},{"key":"BFnrgastro201312_CR126","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1016\/j.vaccine.2006.11.067","volume":"25","author":"RT Ranallo","year":"2007","unstructured":"Ranallo, R. T., Thakkar, S., Chen, Q. & Venkatesan, M. M. Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain. Vaccine 25, 2269\u20132278 (2007).","journal-title":"Vaccine"},{"key":"BFnrgastro201312_CR127","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1016\/j.vaccine.2008.03.079","volume":"26","author":"R McKenzie","year":"2008","unstructured":"McKenzie, R.  et al. Safety and immunogenicity of WRSd1, a live attenuated Shigella dysenteriae type 1 vaccine candidate. Vaccine 26, 3291\u20133296 (2008).","journal-title":"Vaccine"},{"key":"BFnrgastro201312_CR128","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1128\/IAI.70.6.2950-2958.2002","volume":"70","author":"MM Venkatesan","year":"2002","unstructured":"Venkatesan, M. M.  et al. Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine. Infect. Immun. 70, 2950\u20132958 (2002).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR129","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/978-1-4899-1382-1_21","volume":"397","author":"D Cohen","year":"1996","unstructured":"Cohen, D.  et al. Clinical trials of Shigella vaccines in Israel. Adv. Exp. Med. Biol. 397, 159\u2013167 (1996).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFnrgastro201312_CR130","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1128\/iai.59.12.4450-4458.1991","volume":"59","author":"CY Chu","year":"1991","unstructured":"Chu, C. Y.  et al. Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid. Infect. Immun. 59, 4450\u20134458 (1991).","journal-title":"Infect. Immun."},{"key":"BFnrgastro201312_CR131","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/glycob\/cwq136","volume":"21","author":"FX Theillet","year":"2011","unstructured":"Theillet, F. X.  et al. Effects of backbone substitutions on the conformational behavior of Shigella flexneri O-antigens: implications for vaccine strategy. Glycobiology 21, 109\u2013121 (2011).","journal-title":"Glycobiology"},{"key":"BFnrgastro201312_CR132","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1002\/ibd.21247","volume":"16","author":"SC Ng","year":"2010","unstructured":"Ng, S. C., Kamm, M. A., Stagg, A. J. & Knight, S. C. Intestinal dendritic cells: their role in bacterial recognition, lymphocyte homing, and intestinal inflammation. Inflamm. Bowel Dis. 16, 1787\u20131807 (2010).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro201312_CR133","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nri3254","volume":"12","author":"OP Joffre","year":"2012","unstructured":"Joffre, O. P., Segura, E., Savina, A. & Amigorena, S. Cross-presentation by dendritic cells. Nat. Rev. Immunol. 12, 557\u2013569 (2012).","journal-title":"Nat. Rev. Immunol."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2013.12.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2013.12","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2013.12.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T06:20:29Z","timestamp":1744266029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2013.12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,19]]},"references-count":133,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["BFnrgastro201312"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2013.12","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,19]]},"assertion":[{"value":"19 February 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}